Concepedia

Sasha Kravets

SK

13

Publications

1.1K

Citations

12

H-Index

2017

Active since

Affiliations

Brigham and Women's Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

Memorial Sloan Kettering Cancer Center

Massachusetts General Hospital

Sasha Kravets is an author at Brigham and Women's Hospital specializing in oncology, cancer therapeutics, and medicine.

ORCID

Top concepts

Publications per year

2017–2024

13

Publications

13

Safety of Programmed Death–1 Pathway Inhibitors Among Patients With Non–Small-Cell Lung Cancer and Preexisting Autoimmune Disorders

Giulia C. Leonardi, Justin F. Gainor, Mehmet Altan et al. · Journal of Clinical Oncology · 2018 · 351 citations · Full text

, , +20

Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression

Esther Aguilar, Biagio Ricciuti, Justin F. Gainor et al. · Annals of Oncology · 2019 · 318 citations

Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis

Mark M. Awad, Giulia C. Leonardi, Sasha Kravets et al. · Lung Cancer · 2019 · 110 citations · Full text

, , +8

Cytologic‐histologic correlation of programmed death‐ligand 1 immunohistochemistry in lung carcinomas

Eleanor Russell‐Goldman, Sasha Kravets, Suzanne E. Dahlberg et al. · Cancer Cytopathology · 2018 · 92 citations

Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer

Biagio Ricciuti, Sasha Kravets, Suzanne E. Dahlberg et al. · Journal for ImmunoTherapy of Cancer · 2019 · 81 citations · Full text

Rows per page

1–5 of 13